Industrial Bioprocessing Course (Virtual)
Hosted by the Biomanufacturing Innovation Institute (BII) and UMass Lowell
We invite you to join our Industrial Bioprocessing Course. We are planning a 5-day professional short course delivered virtually over 5 weeks from October 5th – November 6th. The course will be taught by industry professionals from BMS, Pfizer, MilliporeSigma, and UMass experts.
The trainees will learn key principles and concepts of industrial bioprocessing of protein, cell and gene therapies. The course covers recent technologies and practices of upstream, downstream and analytical bioprocessing technologies. In addition, FDA initiatives of PAT (Process Analytical Technology), Quality by Design, and Emerging Technology will be covered. The course consists of 7 modules.
Module 1, Upstream Bioprocessing
Module 2, Downstream Bioprocessing
Module 3, Analytical Technology in Bioprocessing
Module 4, Cell Therapy & Bioprocessing
Module 5, Gene Therapy & Bioprocessing
Module 6, Regulatory, QbD, and PAT in Bioprocessing
Module 7, Big data Analytics for Biopharmaceutical
Who can benefit from this professional course
Individuals that are involved in manufacturing, product and process development, regulatory, QA/QC and of biotech therapeutics. Attendees from academia and regulatory agencies may also benefit depending on their areas of interest and level of experience.
Please head over to BlueSnap to complete your registration. For any question about the registration, please contact us at firstname.lastname@example.org. Registration deadline is September 1st, 2020.
For any question, please contact email@example.com